M
BCTXW

Murchinson’s BriaCell Therapeutics Corp Warrant BCTXW Stock Holding History

Murchinson’s Portfolio BCTXW Stock Details BCTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-522,203
Closed -$1.08M – 47
2022
Q4 		$1.08M Sell
522,203
-4,044
-0.8% -$9.43K 0.14% 28
2022
Q3 		$1.51M Hold
526,247
– – 0.44% 26
2022
Q2 		$1.37M Buy
526,247
+56,297
+12% +$180K 0.26% 38
2022
Q1 		$2.44M Buy
469,950
+77,738
+20% +$309K 0.47% 30
2021
Q4 		$1.78M Buy
392,212
+137,775
+54% +$650K 0.17% 48
2021
Q3 		$1.21M Buy
254,437
+154,437
+154% +$379K 0.6% 32
2021
Q2 		$180K Buy
+100,000
New +$125K 0.06% 92

Other funds holding BCTXW

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
KJHP
K.J. Harrison & Partners Toronto, Ontario, Canada $706M AUM 48.92% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $401M AUM 14.95% 1-Year Est. Return

Murchinson's BCTXW Position: Q1 2023 in Review

Murchinson sold out of BriaCell Therapeutics Corp Warrant (BCTXW) in Q1 2023, closing a stake of 522,203 shares — an estimated $1.08M sold.

Murchinson first reported a position in BCTXW in Q2 2021 and held it in 7 quarters. The position peaked at $2.44M in Q1 2022. 4 funds tracked by Wall St. Rank hold BCTXW as of Q1 2023.

  • Murchinson reported no remaining BriaCell Therapeutics Corp Warrant position as of Q1 2023 after selling out during the quarter.
  • Murchinson sold 522,203 BriaCell Therapeutics Corp Warrant shares in Q1 2023, an estimated $1.08M.
  • Murchinson first reported a position in BriaCell Therapeutics Corp Warrant in Q2 2021 and held it in 7 quarters.
  • Murchinson's BriaCell Therapeutics Corp Warrant position peaked at $2.44M in Q1 2022.
  • 4 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q1 2023.

Based on Murchinson's 13F filing for Q1 2023, filed 15 May 2023.